| 55.32 |  +0.30 / +0.55% |
Data as of 3:59pm ET | Day’s Change |
| 55.32 |  0.00 / 0.00% |
Volume: 1.2K |
| Some Numbers at Neogen that Make Your Stock Look Good Jun 17 / MotleyFool.com |
| Previous close | 55.02 |
| Today’s open | 55.14 |
| Day’s range | 54.79 - 55.75 |
| Volume | 68,447 |
| Average volume (3 months) | 65,352 |
| Market cap | $1.3B |
| Dividend yield | -- |
| Earnings growth (last year) | -2.08% |
| Earnings growth (this year) | +20.01% |
| Earnings growth (next 5 years) | +18.50% |
| Revenue growth (last year) | +6.58% |
| P/E ratio | 51.2 |
| Price/Sales | 4.96 |
| Price/Book | 5.94 |
| Today’s change | Today’s % change | |
|---|---|---|
| GHDXGenomic Health Inc | +1.08 | +3.28% |
| VIVOMeridian Bioscience ... | +0.22 | +1.02% |
| QDELQuidel Corp | +0.36 | +1.44% |
| DNDNDendreon Corp | -0.02 | -0.49% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $0.30 |
| Annual revenue (last year) | $184.0M |
| Annual profit (last year) | $22.5M |
| Net profit margin | 12.23% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer James L. Herbert |
President, Chief Operating Officer & Director Lon M. Bohannon, CPA |
Corporate headquarters Lansing, Michigan |
.
